The quest for a single-pill once-a-day treatment for HIV became a reality when the FDA approved Atripla on July 12. It combines the already approved drugs efavirenz (Sustiva), tenofovir (Viread), and ...

A controversial advertisement in DC about an HIV prevention pill has some people calling the commercial effective, but others said the city is taking things too far. Ten years ago, nearly four people ...

You can now live a long and healthy life with HIV, thanks largely to medication that has turned it from a fatal infection and terminal illness into a chronic but manageable condition. Antiretroviral ...

For people like me, the mild, somewhat psychedelic effects from cannabis are nothing compared to the side effects of pharmaceutical pills. When people suggest that medical cannabis shouldn’t be used ...

UCSF researchers are the first to demonstrate that the approach works for the patients who need it the most. Patients who struggle to take daily HIV pills can benefit from long-acting injectable ...

The U.S. Food and Drug Administration last week approved Biktarvy, a one-pill, once-daily combination that contains a new HIV integrase inhibitor and a kidney- and bone-friendly version of tenofovir.

Implementation science data for Apretude (cabotegravir long-acting (CAB LA) for PrEP) demonstrate 95% of participants were happy they switched from oral PrEP to CAB LA Jean van Wyk, MBChB, MFPM, Chief ...